Antifungal peptides: novel therapeutic compounds against emerging pathogens
about
Melanocortin 1 Receptor: Structure, Function, and RegulationAntimicrobial Peptides as Potential Alternatives to Antibiotics in Food Animal IndustryLead optimization of antifungal peptides with 3D NMR structures analysisOviduct-specific expression of human neutrophil defensin 4 in lentivirally generated transgenic chickensSurface-active fungicidal D-peptide inhibitors of the plasma membrane proton pump that block azole resistance.Chemosensitization of fluconazole resistance in Saccharomyces cerevisiae and pathogenic fungi by a D-octapeptide derivative.Sporicidal activity of synthetic antifungal undecapeptides and control of Penicillium rot of applesPharmacokinetic characteristics of caspofungin in two pediatric liver transplant patients.Nasty viruses, costly plasmids, population dynamics, and the conditions for establishing and maintaining CRISPR-mediated adaptive immunity in bacteria.Potent in vitro and in vivo antifungal activity of a small molecule host defense peptide mimic through a membrane-active mechanismHistatin 3-mediated killing of Candida albicans: effect of extracellular salt concentration on binding and internalizationIn vitro susceptibility tests for cationic peptides: comparison of broth microdilution methods for bacteria that grow aerobicallyCorrelation between antifungal susceptibilities of Coccidioides immitis in vitro and antifungal treatment with caspofungin in a mouse model.Novel bifunctional inhibitor of xylanase and aspartic protease: implications for inhibition of fungal growthSymbiotic plant peptides eliminate Candida albicans both in vitro and in an epithelial infection model and inhibit the proliferation of immortalized human cells.Antifungal proteinsBiochemical characterization of an anti-Candida factor produced by Enterococcus faecalisInfluence of histatin 5 on Candida albicans mitochondrial protein expression assessed by quantitative mass spectrometry.Analysis for prevalence and physical linkages amongst integrons, ISEcp1, ISCR1, Tn21 and Tn7 encountered in Escherichia coli strains from hospitalized and non-hospitalized patients in Kenya during a 19-year period (1992-2011).High-throughput nano-biofilm microarray for antifungal drug discoveryRisk factor analysis for extended-spectrum β-lactamase-producing Enterobacter cloacae bloodstream infections in central Taiwan.High-content phenotypic screenings to identify inhibitors of Candida albicans biofilm formation and filamentation.Ultrashort antibacterial and antifungal lipopeptidesAntimicrobial cyclic peptides for plant disease controlClinical and Molecular Epidemiology of Multidrug-Resistant P. aeruginosa Carrying aac(6')-Ib-cr, qnrS1 and blaSPM Genes in Brazil.Human phagocytic cell responses to Scedosporium apiospermum (Pseudallescheria boydii): variable susceptibility to oxidative injuryIn vitro evaluation of double and triple combinations of antifungal drugs against Aspergillus fumigatus and Aspergillus terreusPeptide antimicrobial agents.Peeping into genomic architecture by re-sequencing of Ochrobactrum intermedium M86 strain during laboratory adapted conditions.Metallo beta lactamases in Pseudomonas aeruginosa and Acinetobacter species.Novel expression vector for secretion of cecropin AD in Bacillus subtilis with enhanced antimicrobial activity.Epidemiology and genetics of VIM-type metallo-β-lactamases in Gram-negative bacilli.How multidrug resistance in typhoid fever affects treatment options.Anticandida activity is retained in P-113, a 12-amino-acid fragment of histatin 5.The antifungal protein from Aspergillus giganteus causes membrane permeabilization.Detection of potential risk of wastewater effluents for transmission of antibiotic resistance from Vibrio species as a reservoir in a peri-urban community in South Africa.Impact of self-assembly properties on antibacterial activity of short acyl-lysine oligomers.Interactions between the plasma membrane and the antimicrobial peptide HP (2-20) and its analogues derived from Helicobacter pylori.An invertebrate infection model for evaluating anti-fungal agents against dermatophytosis.Costly Class-1 integrons and the domestication of the the functional integrase.
P2860
Q26745953-9122720D-4242-43CD-B4BC-981CD896493BQ26751499-24122F33-59B4-4B7A-ADDC-AAB21719E106Q27643174-76350541-3B93-4E36-AB86-9E6BC77E7592Q28547573-8B3824BB-4568-4825-816D-24C6CE5476B1Q31136813-D067CC57-6250-4205-B3F0-3944056B398EQ33200348-ABC7704D-9E20-4D1F-8CBC-0C5E4CCD5515Q33484091-6B9F07F5-FB71-45AA-B510-D8B4AE55B6EFQ33739003-0A16AA87-4938-46F5-AC82-2EFBB8AA6D0CQ33742089-34C03D96-FC26-42A2-8357-3F5139343D6CQ33849225-26092D28-FB62-45D6-ABB7-F84AC4383EA4Q33977671-C2D05A3A-FF48-4975-A257-26C7CCDECB06Q33979829-6CD720DA-0A98-4941-91FC-3FDF8F819998Q33982369-1E3AE009-68D3-4FC7-9E78-9005BAF6A858Q33982498-A98A2171-F2A6-4EAD-9BF3-E6B95C9DA9BBQ34177095-E408A53E-390B-401A-8D8F-7FAFE73CED9CQ34293126-FC9FBE3D-2A7F-4069-8AF4-C5AE1806293BQ34325020-5AD82CC4-7DBB-433B-A884-5000870725A3Q34553406-7F390C54-EE22-4616-97A8-E2A9586E4133Q34727309-5F5E7211-F566-4659-81CA-511D14B8780DQ34783867-D2949A04-CC65-44DC-869F-55920E83ED07Q34980196-901445FE-657E-416C-AFBD-823735F2058BQ35119312-78531D6F-7D86-429C-9B77-122A7FA7A53CQ35127593-5049A16F-41EE-40DB-BC2A-A080D526D491Q35168458-723AAEC5-D54B-4B02-9222-79C4EBB9A156Q36027868-FCD6071B-F2E0-4CB4-BAA7-A2BD513AEC19Q36376608-B1210226-E6FC-4BE9-8EAB-ADD7B1479011Q36492208-BB137686-4303-41D1-917E-E8F4D8FAE7EAQ36538861-004A5D6D-B6BC-46B2-B4B0-C88952439C90Q36870098-8AD19194-EDDB-47DB-9E46-745FCA87B600Q37071179-A25DBBBF-D4D7-4E12-96CB-EE00B921B25CQ37333106-70D3B772-BE9B-446F-A2AB-4B9A22BF316AQ37859396-FD1FA197-A2BE-45E1-A8C6-66B0403086BEQ38234712-22855E66-6DA1-4797-9001-F5B828FDF79BQ39477082-0EFF5688-FCD7-4A26-B3A9-C842B4DA01B6Q39740573-CF1F0DEB-DB3F-4AB3-9522-0D5B142FFF0CQ39983213-E884C7BB-B1A1-4B6C-809E-548C8D0BD017Q41390340-CEA9915C-4998-43B3-B02D-BC3AEAE42D70Q41917395-DA3EA3D7-0615-46F4-9F76-9E75AD4CFEAAQ41994258-CF1E46AD-DA6A-4C39-AD11-E3E09098A90CQ42153897-BD1493BD-2EDB-4E3B-87E5-AE00721F73E8
P2860
Antifungal peptides: novel therapeutic compounds against emerging pathogens
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Antifungal peptides: novel therapeutic compounds against emerging pathogens
@ast
Antifungal peptides: novel therapeutic compounds against emerging pathogens
@en
Antifungal peptides: novel therapeutic compounds against emerging pathogens
@nl
type
label
Antifungal peptides: novel therapeutic compounds against emerging pathogens
@ast
Antifungal peptides: novel therapeutic compounds against emerging pathogens
@en
Antifungal peptides: novel therapeutic compounds against emerging pathogens
@nl
prefLabel
Antifungal peptides: novel therapeutic compounds against emerging pathogens
@ast
Antifungal peptides: novel therapeutic compounds against emerging pathogens
@en
Antifungal peptides: novel therapeutic compounds against emerging pathogens
@nl
P2860
P3181
P356
P1476
Antifungal peptides: novel therapeutic compounds against emerging pathogens
@en
P2093
A J De Lucca
P2860
P3181
P356
10.1093/JAC/43.1.1
P407
P577
1999-01-01T00:00:00Z